A previous study found lower baseline levels of IL-33+ cell in MCI patients with AD conversion [20], which was consistent with our study showing a higher peripheral IL-33 non-expression in aMCI patients with AD conversion than non-AD converters. Here, IL33 is linked to Alzheimer disease.